National Cancer Institute Program Project Applications (P01 Clinical Trial Optional)

Funding Agency:
National Institutes of Health

With this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for investigator-initiated Program Project (P01) applications. The proposed Program may address any of the broad areas of cancer research, including (but not limited to) cancer biology, cancer prevention, cancer diagnosis, cancer treatment, and cancer control. Basic, translational, clinical, and/or population-based studies in all of these research areas are appropriate. Each application submitted in response to this FOA must consist of at least three research projects and an Administrative Core. The projects must share a common central theme, focus, and/or overall objective.

Deadlines:

  • Letter of Intent Due Date(s): 30 days prior to the application due date
  • P Series Deadlines: Jan. 25, May 25, Sep. 25
  • AIDS Deadlines: Jan. 7, May 7, Sep. 7

PAR-18-290 Expiration Date January 8, 2020

Agency Website

Eligibility Requirements

The NCI encourages P01 applicants to take advantage of the multiple PD/PI option. The use of this option allows, for example, the designation of any (or all) of the leaders of the individual projects or cores as a PD/PI of the overall application.

Funding Type

Grant

Eligibility

Faculty
Institutional

Category

Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational
Social Sciences

External Deadline

September 25, 2019